Medical Marijuana Inc (OTCMKTS:MJNA) recently announced Hundreds of attendees, speakers, exhibitors, lawmakers, and members of the news media from around the world converged on the International Cannabis Association’s East Coast Regulatory Summit and Educational Conference in Times Square last week.
At the first and largest “pot-preneur” conference and expo to be hosted in New York, many budding entrepreneurs sought guidance from cannabis industry veterans in attendance. HempMeds™ – a Medical Marijuana, Inc. (otc pink:MJNA) portfolio company and the world’s most trusted supplier of natural cannabidiol (CBD) hemp oil products – was a sponsor and exhibitor gaining the attention of multiple media outlets including Yahoo! Finance in the report The Big Trend in Medical Marijuana: Products that Don’t Get you High.
“We are very humbled and grateful to Yahoo! Finance for picking up on this major trend in the cannabis industry,” states Andrew Hard, Director of Public Relations for General Hemp and Spokesperson for HempMeds™. “When it comes to CBD oil from hemp, one simply cannot get ‘stoned’ or ‘high.’ As a result, consumers of CBD hemp oil from HempMeds™ range in age from toddlers to seniors. And cannabis is no longer limited to humans. We are extremely excited to have recently announced aNew Pet nutritional solutions for our four-legged family members.”
To find out what OTCMAGIC projects for Medical Marijuana Inc (OTCMKTS:MJNA) for both short term and long term please click here; MJNA
Medical Marijuana Inc (OTCMKTS:MJNA) mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value.
New York is the most recent state to pass medical marijuana laws and an estimated 900 people explored ways to get into the state’s emerging cannabis industry including HempMeds™ – a MJNA portfolio company and the world’s most trusted supplier of natural cannabidiol (CBD) hemp oil products. The Company proudly showcased current products and unveiled innovations in its CBD hemp oil product line at the International Cannabis Association’s East Coast Regulatory Summit and Educational Conference. New York’s first and largest cannabis business conference was held Oct. 12 and 13 at the Marquis Marriott Hotel in Times Square. There, HempMeds™ participated as an exhibitor and as the conference’s industry party sponsor distributing hemp CBD oil samples to attendees.
To find out what OTCMAGIC projects for Medical Marijuana Inc (OTCMKTS:MJNA) for both short term and long term please click here; MJNA
“Participating in the International Cannabis Association’s New York business conference and expo aided the public with understanding that cannabidiol or ‘CBD’ is available today,” states Andrew Hard, Director of Public Relations for HempMeds™. “To say that we are thrilled at the receptivity of the mainstream news media’s willingness to report on natural CBD hemp oil is an understatement. At the ICA’s business expo, we were inundated by many members of regional, national and global news media with interest in natural CBD oil products on the market and in development.”
The Company has a diversified set of products and services aimed directly at the cannabis and hemp industries. These products include patented cannabinoid-based products and extracts for pharmaceutical, nutraceutical and cosemeceutical industries.
MJNA owns or has partial ownership in the following businesss: Wellness Managed Services 100% Canipa Holdings 80% HempMeds PX 80% Red Dice Holdings 60% CanChew Biotechnologies 50% HempVap™ 50% KannaLife Sciences 16.5%
To find out what OTCMAGIC projects for Medical Marijuana Inc (OTCMKTS:MJNA) for both short term and long term please click here; MJNA
Medical Marijuana Inc (OTCMKTS:MJNA) Stock on Watch!
No comments:
Post a Comment